247 related articles for article (PubMed ID: 27076228)
21. The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS).
Suzuki Y; Enokido Y; Yamada K; Inaba M; Kuwata K; Hanada N; Morishita T; Mizuno S; Wakamatsu N
Oncotarget; 2017 Jul; 8(28):45470-45483. PubMed ID: 28525374
[TBL] [Abstract][Full Text] [Related]
22. Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype.
Lougaris V; Faletra F; Lanzi G; Vozzi D; Marcuzzi A; Valencic E; Piscianz E; Bianco A; Girardelli M; Baronio M; Loganes C; Fasth A; Salvini F; Trizzino A; Moratto D; Facchetti F; Giliani S; Plebani A; Tommasini A
Clin Immunol; 2015 Jul; 159(1):33-6. PubMed ID: 25939554
[No Abstract] [Full Text] [Related]
23. Overlapping phenotypes between SHORT and Noonan syndromes in patients with PTPN11 pathogenic variants.
Ranza E; Guimier A; Verloes A; Capri Y; Marques C; Auclair M; Mathieu-Dramard M; Morin G; Thevenon J; Faivre L; Thauvin-Robinet C; Innes AM; Dyment DA; Vigouroux C; Amiel J
Clin Genet; 2020 Jul; 98(1):10-18. PubMed ID: 32233106
[TBL] [Abstract][Full Text] [Related]
24. Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects.
Jhamnani RD; Nunes-Santos CJ; Bergerson J; Rosenzweig SD
Front Immunol; 2018; 9():2172. PubMed ID: 30319630
[TBL] [Abstract][Full Text] [Related]
25. Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure.
Kwok A; Zvetkova I; Virtue S; Luijten I; Huang-Doran I; Tomlinson P; Bulger DA; West J; Murfitt S; Griffin J; Alam R; Hart D; Knox R; Voshol P; Vidal-Puig A; Jensen J; O'Rahilly S; Semple RK
Mol Metab; 2020 Oct; 40():101020. PubMed ID: 32439336
[TBL] [Abstract][Full Text] [Related]
26. Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity.
Fazel A; Kashef S; Aleyasin S; Harsini S; Karamizadeh Z; Zoghi S; Flores SK; Boztug K; Rezaei N
Allergol Immunopathol (Madr); 2017; 45(1):82-86. PubMed ID: 27789066
[TBL] [Abstract][Full Text] [Related]
27. A novel germline variant in PIK3R1 results in SHORT syndrome associated with TAL/LMO T-cell acute lymphoblastic leukemia.
Marzollo A; Maestrini G; La Starza R; Elia L; Malfona F; Pierini T; Tretti Parenzan C; Coppe A; Bortoluzzi S; Biffi A; Mecucci C; Bresolin S; Testi AM
Am J Hematol; 2020 Dec; 95(12):E335-E338. PubMed ID: 32936972
[No Abstract] [Full Text] [Related]
28. A novel ATM mutation associated with elevated atypical lymphocyte populations, hyper-IgM, and cutaneous granulomas.
Minto H; Mensah KA; Reynolds PR; Meffre E; Rubtsova K; Gelfand EW
Clin Immunol; 2019 Mar; 200():55-63. PubMed ID: 30639167
[TBL] [Abstract][Full Text] [Related]
29. A human immunodeficiency caused by mutations in the PIK3R1 gene.
Deau MC; Heurtier L; Frange P; Suarez F; Bole-Feysot C; Nitschke P; Cavazzana M; Picard C; Durandy A; Fischer A; Kracker S
J Clin Invest; 2014 Sep; 124(9):3923-8. PubMed ID: 25133428
[TBL] [Abstract][Full Text] [Related]
30. Variant PIK3R1 Hypermorphic Mutation and Clinical Phenotypes in a Family with Short Statures, Mild Immunodeficiency and Lymphoma.
Hauck F; Magg T; Krolo A; Bilic I; Hirschmugl T; Laass M; Rösen-Wolff A; Luksch H; Boztug K; Roesler J
Klin Padiatr; 2017 May; 229(3):113-117. PubMed ID: 28561224
[No Abstract] [Full Text] [Related]
31. SHORT syndrome in a two-year-old girl - case report.
Klatka M; Rysz I; Kozyra K; Polak A; Kołłątaj W
Ital J Pediatr; 2017 May; 43(1):44. PubMed ID: 28472977
[TBL] [Abstract][Full Text] [Related]
32. Report of a Chinese Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome.
Wang Y; Wang W; Liu L; Hou J; Ying W; Hui X; Zhou Q; Liu D; Yao H; Sun J; Wang X
J Clin Immunol; 2018 Nov; 38(8):854-863. PubMed ID: 30499059
[TBL] [Abstract][Full Text] [Related]
33. Mutation Profiling of Usual Ductal Hyperplasia of the Breast Reveals Activating Mutations Predominantly at Different Levels of the PI3K/AKT/mTOR Pathway.
Jahn SW; Kashofer K; Thüringer A; Abete L; Winter E; Eidenhammer S; Viertler C; Tavassoli F; Moinfar F
Am J Pathol; 2016 Jan; 186(1):15-23. PubMed ID: 26718977
[TBL] [Abstract][Full Text] [Related]
34. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.
Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA
Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948
[TBL] [Abstract][Full Text] [Related]
35. Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors.
Loconte DC; Grossi V; Bozzao C; Forte G; Bagnulo R; Stella A; Lastella P; Cutrone M; Benedicenti F; Susca FC; Patruno M; Varvara D; Germani A; Chessa L; Laforgia N; Tenconi R; Simone C; Resta N
PLoS One; 2015; 10(4):e0123092. PubMed ID: 25915946
[TBL] [Abstract][Full Text] [Related]
36. Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
Conley ME; Larché M; Bonagura VR; Lawton AR; Buckley RH; Fu SM; Coustan-Smith E; Herrod HG; Campana D
J Clin Invest; 1994 Oct; 94(4):1404-9. PubMed ID: 7523449
[TBL] [Abstract][Full Text] [Related]
37. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling.
Chudasama KK; Winnay J; Johansson S; Claudi T; König R; Haldorsen I; Johansson B; Woo JR; Aarskog D; Sagen JV; Kahn CR; Molven A; Njølstad PR
Am J Hum Genet; 2013 Jul; 93(1):150-7. PubMed ID: 23810379
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of the PI3K catalytic subunit p110δ underlies elevated S6 phosphorylation and protein synthesis in an individual with autism from a multiplex family.
Poopal AC; Schroeder LM; Horn PS; Bassell GJ; Gross C
Mol Autism; 2016; 7():3. PubMed ID: 26770665
[TBL] [Abstract][Full Text] [Related]
39. Insights into the pathological mechanisms of p85α mutations using a yeast-based phosphatidylinositol 3-kinase model.
Oliver MD; Fernández-Acero T; Luna S; Rodríguez-Escudero I; Molina M; Pulido R; Cid VJ
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143957
[TBL] [Abstract][Full Text] [Related]
40. Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility.
Crank MC; Grossman JK; Moir S; Pittaluga S; Buckner CM; Kardava L; Agharahimi A; Meuwissen H; Stoddard J; Niemela J; Kuehn H; Rosenzweig SD
J Clin Immunol; 2014 Apr; 34(3):272-6. PubMed ID: 24610295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
